Arkadios Wealth Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Arkadios Wealth Advisors's FBT Position: Q1 2026 in Review
Arkadios Wealth Advisors opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 1,842 shares worth $370K. The stake represents 0.01% of the portfolio and ranks #1251 among its holdings. This is a return to the name: Arkadios Wealth Advisors previously reported a position in FBT as recently as Q2 2024.
Arkadios Wealth Advisors first reported a position in FBT in Q2 2020 and has held it in 16 quarters since. The position peaked at $620K in Q4 2022. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Arkadios Wealth Advisors held 1,842 shares of First Trust NYSE Arca Biotechnology Index Fund worth $370K as of Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund was a new Arkadios Wealth Advisors position in Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #1251 holding.
- Arkadios Wealth Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 16 quarters since.
- Arkadios Wealth Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $620K in Q4 2022.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.